Short-term safety and immunogenicity of inactivated and peptide-based SARS-CoV-2 vaccines in patients with endocrine-related cancer

BACKGROUND: The aim of this study was to explore the short-term safety and immunogenicity of inactivated and peptide-based SARS-CoV-2 vaccines in patients with endocrine-related cancer (ER). METHODS: Eighty-eight patients with ER cancer and 82 healthy controls who had completed a full course of inac...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Rui, Liu, Li, Pan, Qingbo, Liu, Jin, Tan, Jiahe, Deng, Juan, Deng, Qin, Lin, Zijin, Chen, Min, Peng, Mingli, Ren, Hong, Ming, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637626/
https://www.ncbi.nlm.nih.gov/pubmed/36353624
http://dx.doi.org/10.3389/fimmu.2022.1028246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637626/
https://www.ncbi.nlm.nih.gov/pubmed/36353624
http://dx.doi.org/10.3389/fimmu.2022.1028246

Ejemplares similares